SARS-CoV-2 before and after Omicron: two different viruses and two different diseases?

[1]  K. Bruxvoort,et al.  Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5 , 2023, Nature Communications.

[2]  N. Lo,et al.  Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave , 2023, Nature Medicine.

[3]  C. Donnelly,et al.  Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England , 2022, Nature Communications.

[4]  E. Callaway.  COVID ‘variant soup’ is making winter surges hard to predict , 2022, Nature.

[5]  Jue Liu,et al.  Incubation Period of COVID-19 Caused by Unique SARS-CoV-2 Strains , 2022, JAMA network open.

[6]  Lu Lu,et al.  Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages , 2022, Signal Transduction and Targeted Therapy.

[7]  William T. Harvey,et al.  SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway , 2022, Nature Microbiology.

[8]  M. Lipsitch,et al.  Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in Southern California , 2022, Nature Medicine.

[9]  P. Klenerman,et al.  Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum , 2022, Cell.

[10]  R. Paton,et al.  The rapid replacement of the Delta variant by Omicron (B.1.1.529) in England , 2022, Science Translational Medicine.

[11]  Shu Wan,et al.  SARS-CoV-2 Omicron variant: recent progress and future perspectives , 2022, Signal Transduction and Targeted Therapy.

[12]  S. Bhatt,et al.  Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study , 2022, The Lancet.

[13]  B. Walker,et al.  T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals , 2022, Cell.

[14]  Frances E. Muldoon,et al.  Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity , 2022, Nature.

[15]  A. Sette,et al.  T cell responses to SARS-CoV-2 spike cross-recognize Omicron , 2022, Nature.

[16]  S. Mallapaty.  Where did Omicron come from? Three key theories , 2022, Nature.

[17]  D. Peaper,et al.  Rapid emergence of SARS-CoV-2 Omicron variant is associated with an infection advantage over Delta in vaccinated persons , 2022, Med.

[18]  M. Kraemer,et al.  Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa , 2021, Nature.

[19]  R. Arbel,et al.  Effectiveness of the Bivalent mRNA Vaccine in Preventing Severe COVID-19 Outcomes: An Observational Cohort Study , 2022, SSRN Electronic Journal.

[20]  Fei Shao,et al.  Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies , 2021, bioRxiv.

[21]  Xin He,et al.  SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance , 2021, Signal Transduction and Targeted Therapy.

[22]  Y. Kawaoka,et al.  Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation , 2021, Nature.

[23]  D. Wesemann,et al.  Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant , 2021, Science.

[24]  M. Farzan,et al.  Mechanisms of SARS-CoV-2 entry into cells , 2021, Nature reviews. Molecular cell biology.

[25]  S. Bhatt,et al.  SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion , 2021, Nature.

[26]  D. Wesemann,et al.  Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant , 2021, bioRxiv.

[27]  O. Dym,et al.  SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution , 2021, Nature Microbiology.

[28]  Y. Liu,et al.  The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus , 2021, Journal of travel medicine.

[29]  William T. Harvey,et al.  SARS-CoV-2 variants, spike mutations and immune escape , 2021, Nature Reviews Microbiology.

[30]  R. Neher,et al.  Novel SARS-CoV-2 variants: the pandemics within the pandemic , 2021, Clinical Microbiology and Infection.

[31]  M. Giacca,et al.  Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia , 2021, Nature.

[32]  Gene W. Yeo,et al.  Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States , 2021, Cell.

[33]  M. Beltramello,et al.  N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2 , 2021, Cell.

[34]  M. Beer,et al.  SARS-CoV-2 spike D614G change enhances replication and transmission , 2021, Nature.

[35]  M. Hernán,et al.  BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting , 2021, The New England journal of medicine.

[36]  W. P. Duprex,et al.  Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape , 2021, Science.

[37]  J. Bloom,et al.  Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies , 2021, bioRxiv.

[38]  J. Mascola,et al.  Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine , 2020, The New England journal of medicine.

[39]  P. Ball.  The lightning-fast quest for COVID vaccines — and what it means for other diseases , 2020, Nature.

[40]  P. Dormitzer,et al.  Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine , 2020, The New England journal of medicine.

[41]  M. Beltramello,et al.  Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology , 2020, Cell.

[42]  William L. Hamilton,et al.  Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study , 2020, The Lancet Infectious Diseases.

[43]  K. Yuen,et al.  Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2 , 2020, Cell.

[44]  K. Shi,et al.  Structural basis of receptor recognition by SARS-CoV-2 , 2020, Nature.

[45]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..